Procaps Group S.A. (PROC) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 7Jul 10Nov 25Mar 2Mar 10Mar 13Mar 18Mar 23

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.1x

Market Cap

$103.45M

MomentumView details →

1D Return

+0.00%

YTD Return

—

RSI (14)

27.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.1x

Market Cap

$103.45M

RSI (14)

27.8

MomentumView details →

1D Return

+0.00%

YTD Return

—

ProfitabilityView details →

Gross Margin

55.04%

Net Margin

12.61%

EBITDA Margin

29.04%

ROE (TTM)

132.54%

ROA (TTM)

10.47%

Asset Turnover

0.84x

GrowthView details →

Revenue YoY

−4.80%

EPS YoY

+425.00%

FCF YoY

+96.90%

Revenue CAGR 3Y

+8.07%

EPS CAGR 3Y

+140.78%

EBITDA YoY

+1560.40%

EarningsView details →

EPS (Actual)

$0.08

EPS Surprise

—

Beats (12Q)

4/12

Next Q EPS Est

—

Avg Surprise (4Q)

173.54%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

7.36x

Current Ratio

1.47x

Quick Ratio

0.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

414.10M

Net Income (TTM)

52.20M

Op. CF (TTM)

62.99M

Latest newsMore news →

No recent news for PROC.

Similar companies

Cumberland Pharmaceuticals Inc.CPIX BGM Group Ltd.BGM AlvotechALVOW Huakang Biomedical Holdings Company Limited08622.HK PuraPharm Corporation Limited01498.HK InterCure Ltd.INCR Find similar companies →

Latest newsMore news →

No recent news for PROC.